Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik W Wilker

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Analytical Chemistry|January 23, 2010
Microfluidic preparative free-flow isoelectric focusing: system optimization for protein complex separationJian Wen, Erik W Wilker, Michael B Yaffe, et al.
The Journal of Biological Chemistry|February 26, 2005
A structural basis for 14-3-3sigma functional specificityErik W Wilker, Robert A Grant, Stephen C Artim, et al.
Cancer Research|October 3, 2008
Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2Chunling Yi, Erik W Wilker, Michael B Yaffe, et al.
American Journal of Cancer Research|May 18, 2016
M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrierAndreas Machl, Erik W Wilker, Hui Tian, et al.
Molecular Cell|October 29, 2003
Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1Joseph L Kissil, Erik W Wilker, Kristen C Johnson, et al.
Cancer Research|August 4, 2006
ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in miceAl Charest, Erik W Wilker, Margaret E McLaughlin, et al.
Frontiers in Molecular Biosciences|April 24, 2023
MAPKAP Kinase-2 phosphorylation of PABPC1 controls its interaction with 14-3-3 proteins after DNA damage: A combined kinase and protein array approachJustine R Stehn, Scott R Floyd, Erik W Wilker, et al.
Nature|March 16, 2007
14-3-3sigma controls mitotic translation to facilitate cytokinesisErik W Wilker, Marcel A T M van Vugt, Steven A Artim, et al.
Translational Oncology|January 5, 2025
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancersKimberly J Briggs, Kevin M Cottrell, Matthew R Tonini, et al.
Molecular Cell|December 6, 2011
Chemical genetic screen for AMPKα2 substrates uncovers a network of proteins involved in mitosisMax R Banko, Jasmina J Allen, Bethany E Schaffer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Analytical Chemistry|January 23, 2010
Microfluidic preparative free-flow isoelectric focusing: system optimization for protein complex separationJian Wen, Erik W Wilker, Michael B Yaffe, et al.
The Journal of Biological Chemistry|February 26, 2005
A structural basis for 14-3-3sigma functional specificityErik W Wilker, Robert A Grant, Stephen C Artim, et al.
Cancer Research|October 3, 2008
Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2Chunling Yi, Erik W Wilker, Michael B Yaffe, et al.
American Journal of Cancer Research|May 18, 2016
M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrierAndreas Machl, Erik W Wilker, Hui Tian, et al.
Molecular Cell|October 29, 2003
Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1Joseph L Kissil, Erik W Wilker, Kristen C Johnson, et al.
Cancer Research|August 4, 2006
ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in miceAl Charest, Erik W Wilker, Margaret E McLaughlin, et al.
Frontiers in Molecular Biosciences|April 24, 2023
MAPKAP Kinase-2 phosphorylation of PABPC1 controls its interaction with 14-3-3 proteins after DNA damage: A combined kinase and protein array approachJustine R Stehn, Scott R Floyd, Erik W Wilker, et al.
Nature|March 16, 2007
14-3-3sigma controls mitotic translation to facilitate cytokinesisErik W Wilker, Marcel A T M van Vugt, Steven A Artim, et al.
Translational Oncology|January 5, 2025
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancersKimberly J Briggs, Kevin M Cottrell, Matthew R Tonini, et al.
Molecular Cell|December 6, 2011
Chemical genetic screen for AMPKα2 substrates uncovers a network of proteins involved in mitosisMax R Banko, Jasmina J Allen, Bethany E Schaffer, et al.
Pageof 2